UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 85

Sortiert nach

Co-administration of Fluvastatin and CYP3A4 and CYP2C8 Inhibitors May Increase the Exposure to Fluvastatin in Carriers of CYP2C9 Genetic Variants

Biological and Pharmaceutical Bulletin, 2017/07/01, Vol.40(7), pp.1078-1085

2017

Volltextzugriff (PDF)

Beneficial effects of clazosentan add-on treatment on delayed cerebral microcirculatory disturbances after aneurysmal subarachnoid hemorrhage

Brain hemorrhages, 2024-04, Vol.5 (2), p.62-68

2024

Volltextzugriff (PDF)

27-Hydroxycholesterol suppresses lipid accumulation by down-regulating lipogenic and adipogenic gene expression in 3T3-L1 cells

Cytotechnology (Dordrecht), 2017-06, Vol.69 (3), p.485-492

2017

Volltextzugriff (PDF)

The Complement System and ANCA Associated Vasculitis in the Era of Anti-Complement Drugs

Frontiers in immunology, 2022-06, Vol.13, p.926044-926044

2022

Volltextzugriff (PDF)

IX. Rheumatic Disease and COVID-19

Nihon Naika Gakkai zasshi, 2020-11, Vol.109 (11), p.2301-2306

2020

Volltextzugriff (PDF)

IX. Rheumatic Disease and COVID-19

Nihon Naika Gakkai Zasshi, 2020/11/10, Vol.109(11), pp.2301-2306

2020

Volltextzugriff (PDF)

Association of elevated serum soluble CD226 levels with the disease activity and flares of systemic lupus erythematosus

Scientific reports, 2021-08, Vol.11 (1), p.16162-16162, Article 16162

2021

Volltextzugriff (PDF)

Homeostatic Milieu Induces Production of Deoxyribonuclease 1-like 3 from Myeloid Cells

The Journal of immunology (1950), 2020-04, Vol.204 (8), p.2088-2097

2020

Volltextzugriff (PDF)

Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study

PloS one, 2018-04, Vol.13 (4), p.e0196368-e0196368

2018

Volltextzugriff (PDF)

Hydroxychloroquine versus tacrolimus for the treatment of persistently active systemic lupus erythematosus

Modern rheumatology, 2022-02, Vol.32 (2), p.345-350

2022

Volltextzugriff (PDF)

CCR6+ group 3 innate lymphoid cells accumulate in inflamed joints in rheumatoid arthritis and produce Th17 cytokines

Arthritis research & therapy, 2019-08, Vol.21 (1), p.198-198, Article 198

2019

Volltextzugriff (PDF)

CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan

Arthritis research & therapy, 2019-01, Vol.21 (1), p.30-30, Article 30

2019

Volltextzugriff (PDF)

Predictive factors of fetal and maternal pregnancy outcomes in Japanese patients with systemic lupus erythematosus

Lupus, 2021-09, Vol.30 (10), p.1637-1643

2021

Volltextzugriff (PDF)

Anti-dsDNA IgE induces IL-4 production from basophils, potentially involved in B-cell differentiation in systemic lupus erythematosus

Rheumatology (Oxford, England), 2023-10, Vol.62 (10), p.3480-3489

2023

Volltextzugriff (PDF)

Comparative efficacy and safety of mizoribine and mycophenolate mofetil for treating systemic lupus erythematosus: a retrospective cohort study

Therapeutic advances in musculoskeletal disease, 2022, Vol.14, p.1759720X221096367-1759720X221096367

2022

Volltextzugriff (PDF)

HLA-B52 allele in giant cell arteritis may indicate diffuse large-vessel vasculitis formation: a retrospective study

Arthritis research & therapy, 2021-09, Vol.23 (1), p.1-238, Article 238

2021

Volltextzugriff (PDF)

Antibody response to SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases in Japan: Interim analysis of a multicentre cohort study

Modern rheumatology, 2023-03, Vol.33 (2), p.367-372

2023

Volltextzugriff (PDF)

Clinical course of patients with rheumatoid arthritis who continue or discontinue biologic therapy after hospitalization for infection: a retrospective observational study

Arthritis research & therapy, 2022-06, Vol.24 (1), p.131-131, Article 131

2022

Volltextzugriff (PDF)

CEACAM 1, 3, 5 and 6 -positive classical monocytes correlate with interstitial lung disease in early systemic sclerosis

Frontiers in immunology, 2022-10, Vol.13, p.1016914-1016914

2022

Volltextzugriff (PDF)

Increased Proportion of CD226 + B Cells Is Associated With the Disease Activity and Prognosis of Systemic Lupus Erythematosus

Frontiers in immunology, 2021-07, Vol.12, p.713225-713225

2021

Volltextzugriff (PDF)

Design of Advanced Functional Materials Using Nanoporous Single‐Site Photocatalysts

Chemical record, 2020-07, Vol.20 (7), p.660-671

2020

Volltextzugriff (PDF)

Prognostic improvement and treatment of COVID-19 in patients with rheumatic diseases until December 2022: Analysis of the JCR COVID-19 registry in Japan

Modern rheumatology, 2024-03, Vol.34 (3), p.576-583

2024

Volltextzugriff (PDF)

Genetic basis of lineage-specific evolution of fruit traits in hexaploid persimmon

DNA research, 2023-10, Vol.30 (5)

2023

Volltextzugriff (PDF)

Risk factors for hospitalization or mortality for COVID-19 in patients with rheumatic diseases: Results of a nationwide JCR COVID-19 registry in Japan

Modern rheumatology, 2023-07, Vol.33 (4), p.768-776

2023

Volltextzugriff (PDF)

Activation of caspase-1 is mediated by stimulation of interferon genes and NLR family pyrin domain containing 3 in monocytes of active systemic lupus erythematosus

Clinical and experimental rheumatology, 2022-03, Vol.40 (3), p.522

2022

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(71)

Publikationsform

Sprache

Englisch
(78)
Japanisch
(21)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Co-administration of Fluvastatin and CYP3A4 and CYP2C8 Inhibitors May Increase the Exposure to Fluvastatin in Carriers of CYP2C9 Genetic Variants

Beneficial effects of clazosentan add-on treatment on delayed cerebral microcirculatory disturbances after aneurysmal subarachnoid hemorrhage

27-Hydroxycholesterol suppresses lipid accumulation by down-regulating lipogenic and adipogenic gene expression in 3T3-L1 cells

The Complement System and ANCA Associated Vasculitis in the Era of Anti-Complement Drugs

IX. Rheumatic Disease and COVID-19

IX. Rheumatic Disease and COVID-19

Association of elevated serum soluble CD226 levels with the disease activity and flares of systemic lupus erythematosus

Homeostatic Milieu Induces Production of Deoxyribonuclease 1-like 3 from Myeloid Cells

Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study

Hydroxychloroquine versus tacrolimus for the treatment of persistently active systemic lupus erythematosus

CCR6+ group 3 innate lymphoid cells accumulate in inflamed joints in rheumatoid arthritis and produce Th17 cytokines

CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan

Predictive factors of fetal and maternal pregnancy outcomes in Japanese patients with systemic lupus erythematosus

Anti-dsDNA IgE induces IL-4 production from basophils, potentially involved in B-cell differentiation in systemic lupus erythematosus

Comparative efficacy and safety of mizoribine and mycophenolate mofetil for treating systemic lupus erythematosus: a retrospective cohort study

HLA-B52 allele in giant cell arteritis may indicate diffuse large-vessel vasculitis formation: a retrospective study

Antibody response to SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases in Japan: Interim analysis of a multicentre cohort study

Clinical course of patients with rheumatoid arthritis who continue or discontinue biologic therapy after hospitalization for infection: a retrospective observational study

CEACAM 1, 3, 5 and 6 -positive classical monocytes correlate with interstitial lung disease in early systemic sclerosis

Increased Proportion of CD226 + B Cells Is Associated With the Disease Activity and Prognosis of Systemic Lupus Erythematosus

Design of Advanced Functional Materials Using Nanoporous Single‐Site Photocatalysts

Prognostic improvement and treatment of COVID-19 in patients with rheumatic diseases until December 2022: Analysis of the JCR COVID-19 registry in Japan

Genetic basis of lineage-specific evolution of fruit traits in hexaploid persimmon

Risk factors for hospitalization or mortality for COVID-19 in patients with rheumatic diseases: Results of a nationwide JCR COVID-19 registry in Japan

Activation of caspase-1 is mediated by stimulation of interferon genes and NLR family pyrin domain containing 3 in monocytes of active systemic lupus erythematosus

Suchergebnisse filtern